Navigating the Challenges of Multi-RNA Therapeutics

• SymphoRNA are developing a platform for the delivery of multiRNAs to treat complex diseases, co-ordinating intervention that address complex biological networks
• Discussing why we are taking this approach, and the challenges that we are overcoming to make manufacturing at scale a reality 

Speakers:

Ruth Faram

Co-Founder and CSO

SymphoRNA